Usefulness of early morning urine estrone-3-glucuronide assay in the monitoring ovarian secretory function in precocious puberty.

To evaluate the usefulness of the urinary estrone-3-glucuronide (EI-3-G) in the monitoring of the ovarian function in girls, we studied 11 girls with idiopathic central precocious puberty (ICPP) treated with LHRH analogs (LHRHa) for 2-5 years. Plasma LH, FSH, 17-beta-Estradiol (E2) levels, early morning urine (EMU) E1-3-G concentrations, were assessed before and 3, 6, 12 months after the onset of treatment. As expected, mean basal plasma LH, FSH and E2 concentrations, as well as mean basal EMU E1-3-G levels were significantly (p < 0.01) higher in patients studied than in normal, age matched, prepubertal controls. Three out of the 11 sexually advanced girls showed undetectable (< 15 pg/ml) basal plasma E2 values. On the contrary, in each patient studied, individual basal E1-3-G levels were higher than in normal age-matched prepubertal girls. LHRHa treatment significantly suppressed both basal and peak stimulated plasma gonadotropins, plasma E2 and EMU E1-3-G. However, while serum E2 levels were below the assay detection limit, not allowing to assess the degree of gonadal suppression, E1-3-G urinary concentrations were detectable in each subject treated, in the range of the normal prepubertal values. EMU E1-3-G determination seems to be a very sensitive and reliable approach to the monitoring of the effectiveness of LHRHa treatment in sexually advanced girls, allowing to detect very low estrogen concentrations and to achieve the desired ovarian suppression.
AuthorsF Bassi, O Bartolini, A S Neri, R G Gheri, A Magini, S Bucciantini, V Bruni
JournalJournal of endocrinological investigation (J Endocrinol Invest) Vol. 18 Issue 2 Pg. 98-103 (Feb 1995) ISSN: 0391-4097 [Print] ITALY
PMID7629394 (Publication Type: Journal Article)
Chemical References
  • Estrogens, Conjugated (USP)
  • estrone-3-glucuronide
  • Estrone
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Case-Control Studies
  • Child
  • Estradiol (blood)
  • Estrogens, Conjugated (USP) (urine)
  • Estrone (analogs & derivatives, urine)
  • Female
  • Follicle Stimulating Hormone (blood)
  • Gonadotropin-Releasing Hormone (therapeutic use)
  • Humans
  • Luteinizing Hormone (blood, drug effects)
  • Ovarian Function Tests
  • Ovary (secretion)
  • Puberty, Precocious (drug therapy, physiopathology, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: